Literature DB >> 29191583

Wolf in Sheep's Clothing: Primary Lung Cancer Mimicking Benign Entities.

Annemie Snoeckx1, Amélie Dendooven2, Laurens Carp3, Damien Desbuquoit4, Maarten J Spinhoven5, Patrick Lauwers6, Paul E Van Schil7, Jan P van Meerbeeck8, Paul M Parizel9.   

Abstract

Lung cancer is the most common cancer worldwide. On imaging, it typically presents as mass or nodule. Recognition of these typical cases is often straightforward, whereas diagnosis of uncommon manifestations of primary lung cancer is far more challenging. Lung cancer can mimic a variety of benign entities, including pneumonia, lung abscess, postinfectious scarring, atelectasis, a mediastinal mass, emphysema and granulomatous diseases. Correlation with previous history, clinical and biochemical parameters is necessary in the assessment of these cases, but often aspecific and inconclusive. Whereas 18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography is the cornerstone in staging of lung cancer, its role in diagnosis of these uncommon manifestations is less straightforward since benign entities can present with increased 18F-FDG-uptake and, on the other hand, a number of these uncommon lung cancer manifestations do not exhibit increased uptake. Chest Computed Tomography (CT) is the imaging modality of choice for both lesion detection and characterization. In this pictorial review we present the wide imaging spectrum of CT-findings as well as radiologic-pathologic correlation of these uncommon lung cancer manifestations. Knowledge of the many faces of lung cancer is crucial for early diagnosis and subsequent treatment. A multidisciplinary approach in these cases is mandatory.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  18F–fluorodeoxyglucose positron emission tomography; computed tomography; lung cancer; pulmonary nodule

Mesh:

Substances:

Year:  2017        PMID: 29191583     DOI: 10.1016/j.lungcan.2017.07.037

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  5 in total

1.  Combined model of radiomics, clinical, and imaging features for differentiating focal pneumonia-like lung cancer from pulmonary inflammatory lesions: an exploratory study.

Authors:  Jun-Wei Gong; Zhu Zhang; Tian-You Luo; Xing-Tao Huang; Chao-Nan Zhu; Jun-Wei Lv; Qi Li
Journal:  BMC Med Imaging       Date:  2022-05-24       Impact factor: 2.795

2.  Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial.

Authors:  Rea Bingula; Edith Filaire; Ioana Molnar; Eve Delmas; Jean-Yves Berthon; Marie-Paule Vasson; Annick Bernalier-Donadille; Marc Filaire
Journal:  Respir Res       Date:  2020-05-25

3.  M2 macrophages-derived exosomal microRNA-501-3p promotes the progression of lung cancer via targeting WD repeat domain 82.

Authors:  Jie Lei; Peng Chen; Feng Zhang; Na Zhang; Jianfei Zhu; Xiaoping Wang; Tao Jiang
Journal:  Cancer Cell Int       Date:  2021-02-05       Impact factor: 5.722

4.  M2 macrophage-derived exosomal long non-coding RNA AGAP2-AS1 enhances radiotherapy immunity in lung cancer by reducing microRNA-296 and elevating NOTCH2.

Authors:  Fuquan Zhang; Yonghua Sang; Donglai Chen; Xuejie Wu; Xiaofan Wang; Wentao Yang; Yongbing Chen
Journal:  Cell Death Dis       Date:  2021-05-10       Impact factor: 8.469

5.  Analysis of diagnostic characteristics and clinical related factors of 70 patients with atelectasis by painless bronchoscopy.

Authors:  Qiang Li; Jun Sun; Xuefen Shuai; Junqing Ren; Xuedong Chen
Journal:  Pak J Med Sci       Date:  2022 Jul-Aug       Impact factor: 2.340

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.